CLINICAL RESEARCH: ACUTE MYOCARDIAL INFARCTION
Evolution of Left Ventricular Ejection Fraction and its Relationship to Infarct Size After Acute Myocardial Infarction
Gjin Ndrepepa, MD*,*,
Julinda Mehilli, MD*,
Stefan Martinoff, MD*,
Markus Schwaiger, MD ,
Albert Schömig, MD*, and
Adnan Kastrati, MD*
* Deutsches Herzzentrum, Technische Universität, Munich, Germany
Medizinische Klinik rechts der Isa, Technische Universität, Munich, Germany
Klinik und Poliklinik für Nuklearmedizin rechts der Isar, Technische Universität, Munich, Germany.
Manuscript received January 12, 2007;
revised manuscript received January 31, 2007,
accepted March 6, 2007.
* Reprint requests and correspondence: Dr. Gjin Ndrepepa, Deutsches Herzzentrum, Lazarettstrasse 36, 80636 München, Germany. (Email: ndrepepa{at}dhm.mhn.de).
Objectives: The aim of this study was to investigate the evolution of left ventricular (LV) function and infarct size in patients with acute myocardial infarction (MI) treated with primary coronary stenting.
Background: Little evidence exists on the relationship between LV function and evolution of infarct size after MI.
Methods: This study included 626 patients with first acute MI who underwent 2 angiographic and 3 scintigraphic examinations within 6 months after the acute event. Angiographic left ventricular ejection fraction (LVEF) at baseline and at 6-month angiography, and perfusion defects before intervention and at 7- to 14-day and 6-month scintigraphy after intervention were measured. An analysis of 3-year follow-up was performed.
Results: Scintigraphic perfusion defect (median [25th, 75th percentiles]) was 24.6% [14.0%, 41.0%] of LV before intervention; it was reduced to 11.0% [5.0%, 24.0%] of LV at 7 to 14 days and further to 8.0% [2.0%, 19.0%] of LV at 6 months (p < 0.001). The LVEF was 51.6 ± 12.0% before intervention and increased to 57.4 ± 12.8% at 6 months (p > 0.001). Independent predictors of LVEF change were baseline LVEF (p < 0.001), initial perfusion defect (p < 0.001), early reduction in perfusion defect (p < 0.001), late reduction in perfusion defect (p < 0.001), peak creatine kinase-MB (p < 0.001), and smoking (p = 0.05). Three-year mortality was 1.2% in patients with improved LF function versus 5.6% in patients with worsened LV function (relative risk 0.29, 95% confidence interval 0.09 to 0.90; p = 0.03).
Conclusion: Patients with acute MI show an improvement in LV function and a reduction in infarct size within 6 months after coronary reperfusion. This improvement is associated with better long-term survival.
|
Abbreviations and Acronyms
| | LV = left ventricle/ventricular | | LVEF = left ventricular ejection fraction | | MI = myocardial infarction | | TIMI = Thrombolysis In Myocardial Infarction |
|
Related Article
-
Changes in Infarct Size and Left Ventricular Ejection Fraction: New Prognostic Factors After Acute Myocardial Infarction?
- Bernard De Bruyne and Guy R. Heyndrickx
J. Am. Coll. Cardiol. 2007 50: 157-158.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
S. Orn, C. Manhenke, O. J. Greve, A. I. Larsen, V. V. S. Bonarjee, T. Edvardsen, and K. Dickstein
Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention
Eur. Heart J.,
August 2, 2009;
30(16):
1978 - 1985.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Mehilli, A. Kastrati, S. Schulz, S. Frungel, S. G. Nekolla, W. Moshage, F. Dotzer, K. Huber, J. Pache, J. Dirschinger, et al.
Abciximab in Patients With Acute ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading: A Randomized Double-Blind Trial
Circulation,
April 14, 2009;
119(14):
1933 - 1940.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Bauer, J. Mehilli, P. Barthel, A. Muller, A. Kastrati, K. Ulm, A. Schomig, M. Malik, and G. Schmidt
Impact of Myocardial Salvage Assessed by 99mTc-Sestamibi Scintigraphy on Cardiac Autonomic Function in Patients Undergoing Mechanical Reperfusion Therapy for Acute Myocardial Infarction
J. Am. Coll. Cardiol. Img.,
April 1, 2009;
2(4):
449 - 457.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Funaro, G. La Torre, M. Madonna, L. Galiuto, A. Scara, A. Labbadia, E. Canali, A. Mattatelli, F. Fedele, F. Alessandrini, et al.
Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter study
Eur. Heart J.,
March 1, 2009;
30(5):
566 - 575.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T Shiga, N Hagiwara, H Ogawa, A Takagi, M Nagashima, T Yamauchi, Y Tsurumi, R Koyanagi, H Kasanuki, and for the Heart Institute of Japan Acute Myocardial
Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry
Heart,
February 1, 2009;
95(3):
216 - 220.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. V. Huikuri, K. Kervinen, M. Niemela, K. Ylitalo, M. Saily, P. Koistinen, E.-R. Savolainen, H. Ukkonen, M. Pietila, J. K.E. Airaksinen, et al.
Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction
Eur. Heart J.,
November 2, 2008;
29(22):
2723 - 2732.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Zohlnhofer, A. Dibra, T. Koppara, A. de Waha, R. S. Ripa, J. Kastrup, M. Valgimigli, A. Schomig, and A. Kastrati
Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor for Myocardial Recovery After Acute Myocardial Infarction: A Meta-Analysis
J. Am. Coll. Cardiol.,
April 15, 2008;
51(15):
1429 - 1437.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. I. Jugdutt and A. Jelani
Aging and Defective Healing, Adverse Remodeling, and Blunted Post-Conditioning in the Reperfused Wounded Heart
J. Am. Coll. Cardiol.,
April 8, 2008;
51(14):
1399 - 1403.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. H. Harken
The world of inhibitory {kappa}B
Am J Physiol Heart Circ Physiol,
November 1, 2007;
293(5):
H2624 - H2625.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Evolution of Ejection Fraction and Infarct Size Post-MI
Journal Watch (General),
August 7, 2007;
2007(807):
5 - 5.
[Full Text]
|
|
|
|
|
|
|
B. De Bruyne and G. R. Heyndrickx
Changes in Infarct Size and Left Ventricular Ejection Fraction: New Prognostic Factors After Acute Myocardial Infarction?
J. Am. Coll. Cardiol.,
July 10, 2007;
50(2):
157 - 158.
[Full Text]
[PDF]
|
|
|
|
